![Duane M. Linstrom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Duane M. Linstrom
General Counsel bei
Hirok, Inc.
Profil
Duane M.
Linstrom is currently the General Counsel at Hirok, Inc. He previously worked as Legal Counsel at Canopus Biopharma, Inc. and as Secretary at Taxus Cardium Pharmaceuticals Group, Inc.
Aktive Positionen von Duane M. Linstrom
| Unternehmen | Position | Beginn |
|---|---|---|
Hirok, Inc.
 Hirok, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and sells light weight portable cranes | General Counsel | 20.04.2009 |
Ehemalige bekannte Positionen von Duane M. Linstrom
| Unternehmen | Position | Ende |
|---|---|---|
Taxus Cardium Pharmaceuticals Group, Inc.
 Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Unternehmenssekretär | - |
| BLUE HEAVEN COFFEE, INC | General Counsel | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Hirok, Inc.
Hirok, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and sells light weight portable cranes | Producer Manufacturing |
Canopus Biopharma, Inc.
 Canopus Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals in the areas of antivirals, radiation protection, cancer therapies, camelidae blood products and bio-barcode assay technologies | Health Technology |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
